449325050 | PUO | 44544705 | | 1238555 | 2/10/2005 12:00:00 AM | Cardiomyopathy , LV thrombus | | DIS | Admission Date: 2/8/2005 Report Status: Discharge Date: 2/14/2005 ****** DISCHARGE ORDERS ****** LABRE , MANUELA 542-30-17-1 Spo Gu Room: En Heim Za , New Jersey 75832 Service: MED DISCHARGE PATIENT ON: 11/28/05 AT 02:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: GUMINA , MARJORY SHELA , M.D. CODE STATUS: Full code DISPOSITION: Home w/ services DISCHARGE MEDICATIONS: DIGOXIN 0.25 MG PO QD ENALAPRIL MALEATE 20 MG PO QD Starting IN AM ( 4/16 ) Override Notice: Override added on 4/10/05 by FIGURA , CAREY T. , M.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 79423334 ) POTENTIALLY SERIOUS INTERACTION: ENALAPRIL MALEATE &amp; POTASSIUM CHLORIDE Reason for override: aware Previous override information: Override added on 4/18/05 by FIGURA , CAREY T. , M.D. POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; ENALAPRIL MALEATE Reason for override: aware LASIX ( FUROSEMIDE ) 80 MG PO QD GLIPIZIDE 5 MG PO QD COUMADIN ( WARFARIN SODIUM ) 7.5 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) Food/Drug Interaction Instruction No high Vitamin-K containing foods TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE ) 25 MG PO QD Starting IN AM ( 4/16 ) Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
Number of Doses Required ( approximate ): 2 GABAPENTIN 100 MG PO TID LOVENOX ( ENOXAPARIN ) 60 MG SC Q12H LANTUS ( INSULIN GLARGINE ) 12 UNITS SC QD ARANESP ( DARBEPOETIN ALFA ) 300 MCG SC Q2WEEKS Reason for ordering: Oncology - Chemotherapy Induced Anemia Last known Hgb level at time of order: 12.0 g/dL on 4/18/05 at PUO Symptoms: SOB , Diagnosis: Anemia in Neoplastic Disease 285.22 Treatment Cycle: Maintenance NOVOLOG ( INSULIN ASPART ) 5 UNITS SC AC DIET: Patient should measure weight daily DIET: 2 gram Sodium ACTIVITY: Walking as tolerated FOLLOW UP APPOINTMENT( S ): Dr. Katheryn Gruntz full; Dr. will call Pt. to set up , Dr. Elinore Prazak full until 3/23 Dr. will call Pt to set up earlier appt , Dr. Julieann Geeding at MMC Shingathens Lietperv March , 12:00 PM scheduled , Arrange INR to be drawn on 1/13/05 with f/u INR's to be drawn every 2 days. 
INR's will be followed by Dr. Julieann Geeding ALLERGY: NKA ADMIT DIAGNOSIS: New cardiomyopathy , LV thrombus PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Cardiomyopathy , LV thrombus OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay CMP ( cardiomyopathy ) HTN ( hypertension ) DM ( diabetes mellitus ) breast cancer ( breast cancer ) OPERATIONS AND PROCEDURES: Adenosine-MIBI OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) None BRIEF RESUME OF HOSPITAL COURSE: 71yoF with h/o recurrent breast cancer s/p 2 cycles taxol , one year of herceptin , h/o DM , HTN who p/w one month worsening fatigue and DOE found to have new cardiomyopathy with EF 15% and LV mural thrombus. 
Fatigue began around a month ago when taxol therapy started. 
No CP/PND/orthopnea , no LE edema increasing abd girth or palpitations. 
Pt denies URI sx , no n/v/d , no f/c. 
Can walk barely one flight before DOE , no claudication sx. 
Patient sleep on side with one pillow. 
Noted cardiomegaly and pleural effusion on CT 8/22 ( brca staging ) , subsequent w/u included echo at Tulok 4/25 as described above. 
In ED pt had a negative I +head CT to r/o mets , guaiac negative , started heparin drip with bolus. 
PMH: Brca ( originally dx 1986 , her2 positive ) , HTN , DM , h/o fibroids Meds at home: lantus , metformin , glyburide , enalapril , protonix , aranesp q2wk , zometa. 
PE: T96.8 , hr99 , bp102/60 , r20 , sat 99%3LNC Gen: aox3 , nad , H/N: jvp 10cm water , no thyroid masses , chest few bibasilar rales , heart RRR +s3 , abd soft ntnd nabs , ext wwp , trace pedal edema. 
Labs: Na 130 , K3.5 , gluc 379 , WBC 1.95 with 30% pmn , hct 36 , plt 403 , inr 1.2 , ck/mb/tni negative. 
EKG: NSR at 96bpm , nl volts , no acute STTW changes. 
Head CT negative; CXR small left effusion , cardiomegaly. 
**************hospital course****************** 1 ) Heme: L ventricular mural apical thrombus , confirmed by Echo PUO 7/20/05. 
Head CT on admission showed no evidence of brain mets. 
On therapeutic heparin gtt , goal PTT 60-80 sec , bridging to Coumadin starting at 5 mg PO QD , following INR for goal 2-3. 
INR curr 1.4 , bridging with Lovenox until therapeutic; will set up f/u with Coumadin Clinic. 2 ) Pump: New dilated cardiomyopathy , EF 15% , BNP 230. 
CMP likely due to Herceptin; however , actively ruling out other possible causes , esp ischemic. 
Adenosine-MIBI 6/8/05 converted to planar imaging due to patient claustrophobia/movement , decreased sens/spec c/w MIBI but no obvious concerning perfusion defects on wet read; however , official read was 'non-diagnostic.' Consider Cath or PET as an outpatient. 
ACE , SPEP/UPEP pending. 
Fe studies show iron deficiency , which rules out hemochromatosis. 
TSH decreased at 0.333 , ?hyperthyroidism; T4 wnl , THBR slightly elev. 
Slightly volume overloaded , on Lasix 80 mg PO QD , checking daily I/O's , goal is neg 0.5-1 L daily TBB. 
On Enalapril , low-dose Lopressor , Digoxin 3 ) ID: WBC 1.9 on admission , polys 16% ` ANC ~400. 
Neutropenic on admission , still on precautions , WBC increasing steadily and ANC improving. 
CIS T&gt;100.5. 4 ) Ischemia: Appreciate Cardiology consult Dr. Katheryn Gruntz ( MMC ). 
Toscine Medical Center ( avoiding cath given neutropenia ) on Tuesday 6/8/05 to assess for CAD was non-diagnostic. 
Lopressor , Enalapril 5 ) Endo: DM , HbA1c 8.2%. 
On Lantus 12 mg SC QD , Novolog 5 mg SC QAC , Glipizide 5 mg PO QD , Novolog sliding scale. 
TSH 0.3 , T4 7.7 , THBR 1.29. 
Holding Metformin. 6 ) Renal: Cr 1.0 on admission , h/o DM and HTN , on ACE for renal protection 7 ) Onc: Per Oncology recommendations , continue to hold Herceptin given current EF 15%. 
8 ) PPx: Nexium for GI , heparin. 
9 ) Dispo: Follow-up with Dr. Katheryn Gruntz ( MMC Cards ) , Dr. Elinore Prazak ( MMC Onc ) , Dr. Julieann Geeding ( MMC PCP ). for LV thrombus and prevention of DVT. 
FULL CODE ADDITIONAL COMMENTS: DISCHARGE CONDITION: Stable TO DO/PLAN: Follow-up with Dr. Katheryn Gruntz ( Bea Duna Medical Center ) , Dr. Elinore Prazak ( MMC Onc ) , Dr. Julieann Geeding ( MMC PCP ). 
Note to PCP: Pt is now on Coumadin , needs close INR f/u for the immediate future. 
Pt lives in Quarpat Highway but has a Vi Els Mahunt Lab near home. 
F/u with Onc re change of chemotherapy regimen ( holding Herceptin as likely cause of CMP ). 
No dictated summary ENTERED BY: FIGURA , CAREY T. , M.D. ( VT32 ) 11/28/05 @ 01 ****** END OF DISCHARGE ORDERS ******